How to Get Tirosint in New Hampshire

At a glance
- Drug / Tirosint (levothyroxine sodium) gel capsule or oral liquid by IBSA
- Indication / hypothyroidism, especially malabsorption variants
- Dosing / once daily, taken on an empty stomach
- NH telehealth prescribing / yes, fully permitted
- NH 503A compounding access / yes, licensed pharmacies may ship
- NH Medicaid coverage / not covered as of 2026
- Prescriber types / MD, DO, NP (full practice authority in NH), PA
- Key lab / TSH (plus free T4) required before and 6 to 8 weeks after initiation
- Average cash price / $40 to $130 per month depending on dose and pharmacy
- Manufacturer coupon / IBSA offers a savings card reducing copay for commercially insured patients
Why Tirosint Instead of Standard Levothyroxine?
Tirosint contains levothyroxine sodium in a gel capsule with only four inactive ingredients: gelatin, glycerin, water, and a trace of FD&C dye. Standard levothyroxine tablets contain fillers, dyes, lactose, gluten traces, and other excipients that can interfere with absorption. For patients with celiac disease, lactose intolerance, gastroparesis, or prior bariatric surgery, these excipients create a real clinical problem.
A 2014 study by Vita et al. in Endocrine (N=34) demonstrated that patients with documented GI malabsorption who switched from tablet levothyroxine to a liquid or gel cap formulation achieved normalized TSH levels within 8 weeks, compared to persistently elevated TSH on tablets 1. That finding matters in New Hampshire, where an estimated 4.6% of the adult population carries a hypothyroidism diagnosis according to state health survey data.
The FDA-approved labeling for Tirosint specifies bioequivalence to Synthroid under fasting conditions, but the clinical difference emerges in non-fasting states and malabsorption scenarios. Patients who take PPIs, calcium supplements, or iron within 30 to 60 minutes of dosing tend to absorb gel cap formulations more reliably than tablets 2.
This is not a luxury upgrade. It fills a gap.
Telehealth Prescribing in New Hampshire: What You Need to Know
New Hampshire allows licensed prescribers to issue new prescriptions, including controlled and non-controlled medications, via telehealth without requiring a prior in-person visit. Tirosint is a non-controlled prescription drug, so it falls squarely within telehealth scope.
The New Hampshire Board of Medicine adopted permanent telehealth flexibilities following COVID-era emergency orders. Physicians, nurse practitioners, and physician assistants licensed in New Hampshire (or holding an applicable interstate compact license) can evaluate a patient via synchronous audio-video visit, order labs, and write the prescription electronically 3. New Hampshire grants NPs full practice authority under RSA 326-B, meaning nurse practitioners prescribe independently without a collaborating physician agreement.
A typical telehealth pathway for Tirosint in NH looks like this:
- Patient books a telehealth visit with an endocrinologist, internist, or NP specializing in thyroid disorders
- Provider reviews current labs (TSH, free T4, anti-TPO if autoimmune thyroiditis is suspected)
- Provider discusses the clinical rationale for gel cap over tablet formulation
- E-prescription is sent to the patient's preferred NH pharmacy or a mail-order pharmacy licensed to ship to NH
- Follow-up labs at 6 to 8 weeks confirm dose adequacy
For patients already on stable levothyroxine tablets who want to switch to Tirosint, the conversion is 1:1 by microgram dose. No dose adjustment is needed at the point of switch, according to the American Thyroid Association's 2014 clinical practice guidelines 4.
Lab Requirements Before Starting Tirosint in New Hampshire
Every prescriber in NH will require at minimum a recent TSH level. "Recent" typically means within the past 90 days if the patient has no prior thyroid diagnosis, or within the past 6 months if the patient has a stable, treated history.
The standard pre-prescription lab panel includes:
TSH (thyroid-stimulating hormone): The primary screening and monitoring marker. A TSH above 4.5 mIU/L generally confirms primary hypothyroidism in a symptomatic patient, per the American Association of Clinical Endocrinology (AACE) guidelines 5.
Free T4: Distinguishes overt hypothyroidism (low free T4) from subclinical hypothyroidism (normal free T4 with elevated TSH).
Anti-TPO antibodies: Ordered when Hashimoto's thyroiditis is suspected. Not required for prescribing but changes the long-term monitoring plan.
CBC and metabolic panel: Some telehealth platforms include these to rule out anemia or electrolyte abnormalities that mimic thyroid symptoms.
Labs can be drawn at any Quest Diagnostics, Labcorp, or hospital-affiliated draw site in New Hampshire. Several telehealth platforms partner directly with lab networks to offer bundled lab-and-visit pricing. Turnaround is typically 24 to 48 hours for TSH and free T4.
After starting Tirosint, a follow-up TSH is drawn at 6 to 8 weeks. If the dose is adjusted, another 6-to-8-week interval applies before the next check. Once stable, TSH monitoring shifts to every 6 to 12 months 4.
Pharmacy Access: Retail, Mail-Order, and 503A Compounding
New Hampshire has three distinct channels for obtaining Tirosint or compounded levothyroxine liquid/gel cap formulations.
Retail pharmacy. Major chains (CVS, Walgreens, Rite Aid) and independent pharmacies across NH stock brand-name Tirosint. Availability varies by location. Smaller pharmacies may need 1 to 3 business days to order it. The brand has no AB-rated generic as of May 2026, so "generic substitution" does not apply here.
Mail-order pharmacy. Express Scripts, Caremark, and OptumRx all carry Tirosint. Mail-order tends to reduce per-unit cost on 90-day supplies. Shipping to any NH address is straightforward since levothyroxine does not require cold chain or controlled-substance documentation.
503A compounding pharmacy. New Hampshire permits licensed 503A pharmacies to compound and dispense patient-specific levothyroxine preparations. This becomes relevant when a patient needs a dose not commercially available (Tirosint comes in 13, 25, 50, 75, 88, 100, 112, 125, 137, 150, 175, and 200 mcg) or when cost is prohibitive. A 503A pharmacy compounds the medication against an individual prescription, not in bulk. Several 503A pharmacies based outside NH are licensed to ship into the state.
One distinction matters: 503A-compounded levothyroxine liquid is not FDA-approved Tirosint. Insurance will not treat them interchangeably. If a payer requires "brand Tirosint," a compounded version will not satisfy that requirement.
Insurance and Prior Authorization in New Hampshire
Commercial insurance plans in NH generally cover Tirosint, but the majority place it on Tier 3 (preferred brand) or Tier 4 (non-preferred brand). Expect a copay of $40 to $75 per month on most Tier 3 plans.
Prior authorization is common. Insurers want documentation that the patient cannot tolerate or has failed standard levothyroxine tablets before approving the brand gel cap. The typical PA package includes:
- Diagnosis code: E03.9 (hypothyroidism, unspecified) or E06.3 (autoimmune thyroiditis)
- Documentation of tablet failure or intolerance: GI symptoms on tablets, lab evidence of erratic absorption, confirmed celiac disease, documented lactose intolerance, or post-bariatric anatomy
- Supporting labs: TSH levels showing poor control on tablets vs. improvement on gel cap trial (if available)
- Prescriber attestation: A brief letter or form stating medical necessity
PA turnaround in NH ranges from 48 hours to 14 business days. Many telehealth platforms handle PA submission as part of their service. If denied, New Hampshire insurance law (RSA 420-J:7-a) grants the right to an external review by an independent review organization within 45 days of the denial.
NH Medicaid (NH Healthy Families / Well Sense): As of 2026, Tirosint is not on the New Hampshire Medicaid preferred drug list. Patients on Medicaid may apply for a medical exception, but approval rates are low without strong documentation of malabsorption. The out-of-pocket cash route or 503A compounding may be more practical for Medicaid beneficiaries.
Cash pay options: GoodRx and RxSaver report Tirosint cash prices at NH pharmacies ranging from $42 for the 13 mcg dose to $128 for 200 mcg (30-day supply). IBSA offers a manufacturer savings card that can reduce commercially insured copays to as low as $0 to $25 per fill. The savings card does not apply to government insurance (Medicaid, Medicare Part D, Tricare).
Who Can Prescribe Tirosint in New Hampshire?
Three provider types hold prescriptive authority in New Hampshire:
Physicians (MD/DO). Any physician licensed by the New Hampshire Board of Medicine can prescribe Tirosint. Endocrinologists are the specialty most familiar with gel cap formulations, but internists and family medicine doctors prescribe it regularly.
Nurse practitioners (APRN). New Hampshire is a full practice authority state. NPs with prescriptive authority can independently diagnose hypothyroidism, order labs, prescribe Tirosint, and manage ongoing dose titration without physician oversight 6.
Physician assistants (PA). PAs in NH prescribe under a collaborative agreement with a supervising physician. The supervising physician does not need to be present or co-sign the Tirosint prescription in real time, but the agreement must be on file.
All three provider types can prescribe via telehealth. No additional licensing endorsement is required beyond the standard NH medical license and DEA registration (DEA registration is technically required for all prescribers in NH, even for non-controlled medications, because the e-prescribing infrastructure routes through DEA-linked EPCS systems).
Switching to Tirosint: Clinical Timeline
Patients switching from levothyroxine tablets to Tirosint should expect the following timeline in NH:
Week 0: Telehealth or in-person visit. Labs reviewed or ordered. Prescription sent electronically to pharmacy.
Days 1 to 3: Pharmacy fills or orders Tirosint. Most retail pharmacies have it within 2 business days. Mail-order ships within 3 to 5 business days.
Weeks 1 to 4: Patient takes Tirosint daily, same dose as prior tablet. Symptom changes (energy, weight, mood) may begin within 2 to 3 weeks but full steady-state requires 5 to 6 half-lives of levothyroxine. The half-life of T4 is approximately 7 days, so steady state arrives around week 5 to 6 7.
Week 6 to 8: Follow-up TSH and free T4 drawn. Provider adjusts dose if needed. Adjustments are typically made in 12.5 to 25 mcg increments.
Month 3 to 6: If dose is stable and TSH is within target range (0.5 to 2.5 mIU/L for most adults, per AACE), monitoring shifts to every 6 months.
The entire process from first appointment to confirmed stable dosing takes 8 to 12 weeks for most patients. Patients with prior bariatric surgery or active celiac disease often see faster normalization of TSH on gel cap compared to their tablet history, based on the Vita et al. data 1.
Transferring a Tirosint Prescription to New Hampshire
Patients moving to NH or visiting from another state can transfer an existing Tirosint prescription. NH participates in standard interstate prescription transfer protocols. The process:
- Contact your new NH pharmacy with the name and phone number of your current out-of-state pharmacy
- The receiving pharmacist calls the originating pharmacy and transfers remaining refills
- Controlled substances have transfer restrictions, but levothyroxine is not scheduled, so transfers are straightforward
Alternatively, a telehealth provider licensed in NH can write a new prescription based on your existing records and recent labs. This is often faster than a pharmacy-to-pharmacy transfer and avoids issues with expired refills. Most telehealth platforms can have a new e-prescription at your NH pharmacy within 24 hours of the visit.
If you are a seasonal resident (NH has a significant seasonal population), confirm that your pharmacy benefits cover fills in NH. Most national PBMs (Express Scripts, Caremark, OptumRx) process claims regardless of fill state, but some regional plans restrict out-of-state fills.
What to Expect on Cost Without Insurance
For NH residents paying cash, the math is direct. Brand Tirosint at a retail pharmacy costs roughly $1.40 to $4.30 per capsule depending on strength. A 30-day supply runs $42 to $128. A 90-day mail-order supply often reduces cost by 10 to 15%.
503A compounded levothyroxine liquid or capsules from an NH-licensed pharmacy may cost $30 to $60 per month, depending on dose and compounding fees. The trade-off is that compounded preparations lack the batch-to-batch potency consistency guarantee of FDA-approved products.
The IBSA manufacturer savings program (tirosint.com) can bring commercially insured copays down to $0 to $25. Eligibility requires commercial insurance. Patients on Medicare Part D, Medicaid, or Tricare are excluded. For uninsured patients, IBSA also offers a patient assistance program with income-based eligibility.
Frequently asked questions
›How do I get a Tirosint prescription in New Hampshire?
›What labs are needed before Tirosint in New Hampshire?
›Are there telehealth providers in New Hampshire prescribing Tirosint?
›How long until I receive Tirosint in New Hampshire?
›Can I transfer a Tirosint prescription to New Hampshire?
›Are 503A pharmacies in New Hampshire licensed to ship levothyroxine liquid or gel cap?
›Who can prescribe Tirosint in New Hampshire: MD vs NP vs PA?
›What documentation does prior authorization require in New Hampshire?
›Does New Hampshire Medicaid cover Tirosint?
›What does Tirosint cost without insurance in New Hampshire?
›Is there a manufacturer coupon for Tirosint?
›Can I take Tirosint with coffee or food?
References
- Vita R, Saraceno G, Trimarchi F, Benvenga S. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors. Endocrine. 2014;46(3):452-456. https://pubmed.ncbi.nlm.nih.gov/25168316/
- Tirosint (levothyroxine sodium) prescribing information. IBSA. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/
- Kichloo A, Albosta M, Dettloff K, et al. Telemedicine, the current COVID-19 pandemic and the future: a narrative review and perspectives moving forward in the USA. Fam Med Community Health. 2020;8(3):e000530. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075526/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028. https://pubmed.ncbi.nlm.nih.gov/22954017/
- Iyer S. The role of nurse practitioners in the United States: past, present, and future. J Nurse Pract. 2016;12(10):631-635. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047755/
- Biondi B, Wartofsky L. Treatment with thyroid hormone. Endocr Rev. 2014;35(3):433-512. https://pubmed.ncbi.nlm.nih.gov/24297018/